Combining Latency Reversing Agents to Address the HIV Reservoir
Combining Latency Reversing Agents to Address the HIV Reservoir
Not yet recruiting · NCT07384624 · Registry updated 2026-02-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combining Latency Reversing Agents to Address the HIV Reservoir | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 1 / Phase 2 | 2026-02-03 | NCT07384624 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Erasmus Medical Center | 271 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam University Medical Center | Amsterdam | Netherlands | 35 |
| Erasmus MC | Rotterdam | Netherlands | 57 |
| Radboud University Medical Center | Nijmegen | Netherlands | 40 |
| University Medical Center Utrecht | Utrecht | Netherlands | 28 |